Loading clinical trials...
Loading clinical trials...
A Pilot Study of Zimberelimab and Quemliclustat Combination With Chemotherapy in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Conditions
Interventions
Biospecimen Collection
Computed Tomography
+8 more
Locations
1
United States
Yonemoto,Lisa
Los Angeles, California, United States
Start Date
March 7, 2023
Primary Completion Date
December 1, 2026
Completion Date
March 2, 2027
Last Updated
January 15, 2026
NCT07240766
NCT05825066
NCT07101679
NCT05356039
NCT04481204
NCT04669197
Lead Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions